Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
:6618
RESEARCH TOOLSreports
Total Valuation
JD Health International, Inc. has a market cap or net worth of HK$204.41B. The enterprise value is HK$83.49B.
Market CapHK$204.41B
Enterprise ValueHK$83.49B
Share Statistics
JD Health International, Inc. has 3,201,475,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,201,475,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
JD Health International, Inc.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 1.80%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)1.80%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee16.32M
Profits Per Employee1.17M
Employee Count3,564
Asset Turnover0.82
Inventory Turnover7.68
Valuation Ratios
The current PE Ratio of JD Health International, Inc. is 39.5. JD Health International, Inc.’s PEG ratio is ―.
PE Ratio39.5
PS Ratio―
PB Ratio―
Price to Fair Value1.51
Price to FCF―
Price to Operating Cash Flow42.65
PEG Ratio―
Income Statement
In the last 12 months, JD Health International, Inc. had revenue of 58.16B and earned 4.16B in profits. Earnings per share was 1.32.
Revenue58.16B
Gross Profit13.31B
Operating Income1.16B
Pretax Income4.80B
Net Income4.16B
EBITDA1.31B
Earnings Per Share (EPS)1.32
Cash Flow
In the last 12 months, operating cash flow was 4.33B and capital expenditures 0.00, giving a free cash flow of 4.33B billion.
Operating Cash Flow4.33B
Free Cash Flow4.33B
Free Cash Flow per Share1.35
Dividends & Yields
JD Health International, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change166.04%
50-Day Moving Average52.88
200-Day Moving Average38.61
Relative Strength Index (RSI)64.13
Average Volume (3m)11.45M
Important Dates
JD Health International, Inc. upcoming earnings date is Mar 30, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateMar 30, 2026
Ex-Dividend Date―
Financial Position
JD Health International, Inc. as a current ratio of 3.77, with Debt / Equity ratio of 0.47%
Current Ratio3.77
Quick Ratio3.39
Debt to Market Cap0.00
Net Debt to EBITDA-17.01
Interest Coverage Ratio141.92
Taxes
In the past 12 months, JD Health International, Inc. has paid 639.66M in taxes.
Income Tax639.66M
Effective Tax Rate0.13
Enterprise Valuation
JD Health International, Inc. EV to EBITDA ratio is 46.27, with an EV/FCF ratio of 14.19.
EV to Sales1.05
EV to EBITDA46.27
EV to Free Cash Flow14.19
EV to Operating Cash Flow14.04
Balance Sheet
JD Health International, Inc. has HK$51.24B in cash and marketable securities with HK$258.39M in debt, giving a net cash position of -HK$50.98B billion.
Cash & Marketable SecuritiesHK$51.24B
Total DebtHK$258.39M
Net Cash-HK$50.98B
Net Cash Per Share-HK$15.92
Tangible Book Value Per ShareHK$16.86
Margins
Gross margin is 22.88%, with operating margin of 2.00%, and net profit margin of 7.16%.
Gross Margin22.88%
Operating Margin2.00%
Pretax Margin8.25%
Net Profit Margin7.16%
EBITDA Margin2.26%
EBIT Margin2.00%
Analyst Forecast
The average price target for JD Health International, Inc. is HK$71.19, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$71.19
Price Target Upside11.50% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast18.56%
EPS Growth Forecast79.54%